Valuation: Divi's Laboratories Limited

Market Cap 2,282B 23.85B 20.43B 19.12B 17.5B 32.84B 33.28B 226B 88.08B 1,146B 89.57B 87.62B 3,792B P/E 2027 *
70.2x
P/E 2028 * 58.1x
Enterprise Value 2,247B 23.49B 20.12B 18.82B 17.23B 32.34B 32.77B 222B 86.73B 1,129B 88.19B 86.27B 3,734B EV / Sales 2027 *
17.9x
EV / Sales 2028 * 14.9x
Free-Float
48.01%
Yield 2027 *
0.41%
Yield 2028 * 0.45%
1 day-1.04%
1 week+0.31%
Current month+5.60%
1 month+17.37%
3 months+25.92%
6 months+36.00%
Current year+33.09%
1 week 8,457.5
Extreme 8457.5
8,630
1 month 7,220.5
Extreme 7220.5
8,674
Current year 5,647.5
Extreme 5647.5
8,674
1 year 5,636.5
Extreme 5636.5
8,674
3 years 3,295.3
Extreme 3295.3
8,674
5 years 2,730
Extreme 2730
8,674
10 years 532.65
Extreme 532.65
8,674
Manager TitleAgeSince
Chief Executive Officer 48 04/01/2020
Chief Executive Officer 75 26/11/2009
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Chairman 75 26/11/2009
Director/Board Member 48 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%+0.31%+36.15%+132.18% 23.85B
+0.88%+6.38%+76.40%+126.87% 1,119B
+1.07%+3.80%+50.73%+64.25% 651B
+1.20%+6.21%+25.81%+80.15% 468B
-1.50%+4.10%+42.63%+42.49% 374B
-0.57%+2.85%+25.37%+41.24% 302B
-1.03%+4.95%+2.19%+12.86% 259B
+1.29%+5.81%+49.57%+70.71% 238B
+0.44%+3.42%-17.67%-53.17% 208B
+1.87%+5.61%+27.32%+89.67% 181B
Average +0.26%+4.80%+31.85%+60.72% 382.37B
Weighted average by Cap. +0.51%+5.37%+44.12%+72.74%

Financials

2027 *2028 *
Net sales 126B 1.31B 1.13B 1.05B 964M 1.81B 1.83B 12.44B 4.85B 63.13B 4.93B 4.82B 209B 150B 1.57B 1.34B 1.26B 1.15B 2.16B 2.19B 14.83B 5.79B 75.3B 5.88B 5.75B 249B
Net income 32.57B 340M 292M 273M 250M 469M 475M 3.22B 1.26B 16.36B 1.28B 1.25B 54.11B 39.37B 411M 352M 330M 302M 567M 574M 3.9B 1.52B 19.78B 1.54B 1.51B 65.41B
Net Debt -35B -366M -313M -293M -268M -504M -510M -3.46B -1.35B -17.58B -1.37B -1.34B -58.15B -44.85B -469M -402M -376M -344M -645M -654M -4.44B -1.73B -22.53B -1.76B -1.72B -74.53B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
24/08/26 INR 8,507.00 -1.05% 210,392
21/08/26 INR 8,597.00 +0.32% 180,697
20/08/26 INR 8,570.00 +0.12% 198,190
19/08/26 INR 8,560.00 -0.33% 179,152
18/08/26 INR 8,588.00 +1.26% 404,163
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
8,597.00INR
Average target price
8,292.48INR
Spread / Average Target
-3.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock